☰

Jill A. Hollway, Ph.D. - Publications

Affiliations: 
2012 Psychology Ohio State University, Columbus, Columbus, OH 
Area:
Physiological Psychology
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

39 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Arnold LE, Arns M, Barterian JA, Connor S, deBeus RJ, Hollway JA, Kerson C, Lightstone H, Lubar JF, McBurnett K, Monastra VJ, Mulligan A, Buchan-Page K, Pan XJ, Rice R, et al. Neurofeedback for Attention-Deficit/Hyperactivity Disorder: 25-Month Follow-up of Double-Blind Randomized Controlled Trial. Journal of the American Academy of Child and Adolescent Psychiatry. PMID 36521694 DOI: 10.1016/j.jaac.2022.07.862  0.341
2021 Bodfish JW, Lecavalier L, Harrop C, Dallman A, Kalburgi SN, Hollway J, Faldowski R, Boyd BA. Measuring the Functional Impact of Behavioral Inflexibility in Children with Autism Using the Behavioral Inflexibility Scale: Clinical Interview (BIS-CI). Journal of Autism and Developmental Disorders. PMID 33811282 DOI: 10.1007/s10803-021-04984-z  0.36
2020 Arnold LE, Arns M, Barterian J, Bergman R, Black S, Conners CK, Connor S, Dasgupta S, deBeus R, Higgins T, Hirshberg L, Hollway J, Kerson C, Lightstone H, et al. Double-Blind Placebo-Controlled Randomized Clinical Trial of Neurofeedback for Attention-Deficit/Hyperactivity Disorder With 13 Month Follow-up. Journal of the American Academy of Child and Adolescent Psychiatry. PMID 32853703 DOI: 10.1016/J.Jaac.2020.07.906  0.454
2020 Maddox BB, Lecavalier L, Miller JS, Pritchett J, Hollway J, White SW, Gillespie S, Evans AN, Schultz RT, Herrington JD, Bearss K, Scahill L. Reliability and validity of the Pediatric Anxiety Rating Scale modified for autism spectrum disorder. Autism : the International Journal of Research and Practice. 1362361320922682. PMID 32476441 DOI: 10.1177/1362361320922682  0.445
2019 Arnold LE, Luna RA, Williams K, Chan J, Parker RA, Wu Q, Hollway JA, Jeffs A, Lu F, Coury DL, Hayes C, Savidge T. Probiotics for Gastrointestinal Symptoms and Quality of Life in Autism: A Placebo-Controlled Pilot Trial. Journal of Child and Adolescent Psychopharmacology. PMID 31478755 DOI: 10.1089/Cap.2018.0156  0.475
2018 Barrie ES, Pinsonneault JK, Sadee W, Hollway JA, Handen BL, Smith T, Arnold LE, Butter E, Hansen-Kiss E, Herman GE, Aman MG. Testing genetic modifiers of behavior and response to atomoxetine in autism spectrum disorder with ADHD. Journal of Developmental and Physical Disabilities. 30: 355-371. PMID 30197492 DOI: 10.1007/S10882-018-9590-4  0.572
2018 Arnold LE, Ober N, Aman MG, Handen B, Smith T, Pan X, Hyman SL, Hollway J, Lecavalier L, Page K, Rice R. A 1.5-Year Follow-Up of Parent Training and Atomoxetine for Attention-Deficit/Hyperactivity Disorder Symptoms and Noncompliant/Disruptive Behavior in Autism. Journal of Child and Adolescent Psychopharmacology. PMID 29694241 DOI: 10.1089/Cap.2017.0134  0.673
2018 Aman MG, Hollway JA, Veenstra-VanderWeele J, Handen BL, Sanders KB, Chan J, Macklin E, Arnold LE, Wong T, Newsom C, Hastie Adams R, Marler S, Peleg N, Anagnostou EA. Effects of Metformin on Spatial and Verbal Memory in Children with ASD and Overweight Associated with Atypical Antipsychotic Use. Journal of Child and Adolescent Psychopharmacology. PMID 29620914 DOI: 10.1089/Cap.2017.0072  0.555
2017 Hollway JA, Mendoza-Burcham M, Andridge R, Aman MG, Handen B, Arnold LE, Lecavalier L, Williams C, Silverman L, Smith T. Atomoxetine, Parent Training, and Their Effects on Sleep in Youth with Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. PMID 29112459 DOI: 10.1089/Cap.2017.0085  0.659
2017 Lecavalier L, Pan X, Smith T, Handen BL, Arnold LE, Silverman L, Tumuluru RV, Hollway J, Aman MG. Parent Stress in a Randomized Clinical Trial of Atomoxetine and Parent Training for Children with Autism Spectrum Disorder. Journal of Autism and Developmental Disorders. PMID 29022125 DOI: 10.1007/S10803-017-3345-4  0.645
2017 Handen BL, Anagnostou E, Aman MG, Sanders KB, Chan J, Hollway JA, Brian J, Arnold LE, Capano L, Williams C, Hellings JA, Butter E, Mankad D, Tumuluru R, Kettel J, et al. A Randomized, Placebo-Controlled Trial of Metformin for the Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorder: Open-Label Extension. Journal of the American Academy of Child and Adolescent Psychiatry. 56: 849-856.e6. PMID 28942807 DOI: 10.1016/J.Jaac.2017.07.790  0.618
2017 Tumuluru RV, Corbett-Dick P, Aman MG, Smith T, Arnold LE, Pan X, Buchan-Page KA, Brown NV, Ryan MM, Hyman SL, Hellings J, Williams C, Hollway JA, Lecavalier L, Rice RR, et al. Adverse Events of Atomoxetine in a Double-Blind Placebo-Controlled Study in Children with Autism. Journal of Child and Adolescent Psychopharmacology. PMID 28509573 DOI: 10.1089/Cap.2016.0187  0.679
2016 Smith T, Aman MG, Arnold LE, Silverman LB, Lecavalier L, Hollway J, Tumuluru R, Hyman SL, Buchan-Page KA, Hellings J, Rice RR, Brown NV, Pan X, Handen BL. Atomoxetine and Parent Training for Children With Autism and Attention-Deficit/Hyperactivity Disorder: A 24-Week Extension Study. Journal of the American Academy of Child and Adolescent Psychiatry. 55: 868-876.e2. PMID 27663942 DOI: 10.1016/J.Jaac.2016.06.015  0.687
2016 Anagnostou E, Aman MG, Handen BL, Sanders KB, Shui A, Hollway JA, Brian J, Arnold LE, Capano L, Hellings JA, Butter E, Mankad D, Tumuluru R, Kettel J, Newsom CR, et al. Metformin for Treatment of Overweight Induced by Atypical Antipsychotic Medication in Young People With Autism Spectrum Disorder: A Randomized Clinical Trial. Jama Psychiatry. PMID 27556593 DOI: 10.1001/Jamapsychiatry.2016.1232  0.633
2016 Hollway JA, Aman MG, Mendoza-Burcham MI, Silverman L, Arnold LE, Tumuluru R, Handen BL, Lecavalier L, Page K, Sayre P, Smith T. Caregiver Satisfaction with a Multisite Trial of Atomoxetine and Parent Training for Attention-Deficit/Hyperactivity Disorder and Behavioral Noncompliance in Children with Autism Spectrum Disorder. Journal of Child and Adolescent Psychopharmacology. PMID 26797318 DOI: 10.1089/Cap.2015.0130  0.637
2015 Handen BL, Aman MG, Arnold LE, Hyman SL, Tumuluru RV, Lecavalier L, Corbett-Dick P, Pan X, Hollway JA, Buchan-Page KA, Silverman LB, Brown NV, Rice RR, Hellings J, Mruzek DW, et al. Atomoxetine, Parent Training, and Their Combination in Children With Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder. Journal of the American Academy of Child and Adolescent Psychiatry. 54: 905-15. PMID 26506581 DOI: 10.1016/J.Jaac.2015.08.013  0.671
2015 Aman M, Rettiganti M, Nagaraja HN, Hollway JA, McCracken J, McDougle CJ, Tierney E, Scahill L, Arnold LE, Hellings J, Posey DJ, Swiezy NB, Ghuman J, Grados M, Shah B, et al. Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial. Journal of Child and Adolescent Psychopharmacology. 25: 482-93. PMID 26262903 DOI: 10.1089/Cap.2015.0005  0.553
2015 Aman MG, Arnold LE, Hollway JA. Assessing change in core autism symptoms: challenges for pharmacological studies. Journal of Child and Adolescent Psychopharmacology. 25: 282-5. PMID 25978740 DOI: 10.1089/Cap.2015.28999.Mga  0.629
2014 Silverman L, Hollway JA, Smith T, Aman MG, Arnold LE, Pan X, Li X, Handen BL. A Multisite Trial of Atomoxetine and Parent Training in Children with Autism Spectrum Disorders: Rationale and Design Challenges. Research in Autism Spectrum Disorders. 8: 899-907. PMID 25197320 DOI: 10.1016/J.Rasd.2014.03.013  0.679
2014 Aman MG, Smith T, Arnold LE, Corbett-Dick P, Tumuluru R, Hollway JA, Hyman SL, Mendoza-Burcham M, Pan X, Mruzek DW, Lecavalier L, Levato L, Silverman LB, Handen B. A review of atomoxetine effects in young people with developmental disabilities. Research in Developmental Disabilities. 35: 1412-24. PMID 24732041 DOI: 10.1016/J.Ridd.2014.03.006  0.639
2013 Handen BL, Johnson CR, Butter EM, Lecavalier L, Scahill L, Aman MG, McDougle CJ, Arnold LE, Swiezy NB, Sukhodolsky DG, Mulick JA, White SW, Bearss K, Hollway JA, Stigler KA, et al. Use of a Direct Observational Measure in a Trial of Risperidone and Parent Training in Children with Pervasive Developmental Disorders. Journal of Developmental and Physical Disabilities. 25: 355-371. PMID 23730123 DOI: 10.1007/S10882-012-9316-Y  0.574
2013 Hollway JA, Aman MG, Butter E. Correlates and risk markers for sleep disturbance in participants of the Autism Treatment Network. Journal of Autism and Developmental Disorders. 43: 2830-43. PMID 23624832 DOI: 10.1007/S10803-013-1830-Y  0.577
2012 Arnold LE, Aman MG, Hollway J, Hurt E, Bates B, Li X, Farmer C, Anand R, Thompson S, Ramadan Y, Williams C. Placebo-controlled pilot trial of mecamylamine for treatment of autism spectrum disorders. Journal of Child and Adolescent Psychopharmacology. 22: 198-205. PMID 22537359 DOI: 10.1089/Cap.2011.0056  0.55
2012 Scahill L, McDougle CJ, Aman MG, Johnson C, Handen B, Bearss K, Dziura J, Butter E, Swiezy NG, Arnold LE, Stigler KA, Sukhodolsky DD, Lecavalier L, Pozdol SL, Nikolov R, ... Hollway JA, et al. Effects of risperidone and parent training on adaptive functioning in children with pervasive developmental disorders and serious behavioral problems. Journal of the American Academy of Child and Adolescent Psychiatry. 51: 136-46. PMID 22265360 DOI: 10.1016/J.Jaac.2011.11.010  0.65
2011 Hollway JA, Aman MG. Sleep correlates of pervasive developmental disorders: a review of the literature. Research in Developmental Disabilities. 32: 1399-421. PMID 21570809 DOI: 10.1016/J.Ridd.2011.04.001  0.552
2011 Hollway JA, Aman MG. Pharmacological treatment of sleep disturbance in developmental disabilities: a review of the literature. Research in Developmental Disabilities. 32: 939-62. PMID 21296553 DOI: 10.1016/J.Ridd.2010.12.035  0.549
2010 Aman MG, Arnold LE, Lecavalier L, Hollway JA, Mulick JA, McDougle CJ, Swiezy NB, Stigler KA, Handen BL, Johnson C, Vitiello B, Bearss K, Dziura J, Scahill L. Dr. Aman et al. reply Journal of the American Academy of Child and Adolescent Psychiatry. 49: 407-408. DOI: 10.1097/00004583-201004000-00016  0.342
2009 Aman MG, McDougle CJ, Scahill L, Handen B, Arnold LE, Johnson C, Stigler KA, Bearss K, Butter E, Swiezy NB, Sukhodolsky DD, Ramadan Y, Pozdol SL, Nikolov R, Lecavalier L, ... ... Hollway JA, et al. Medication and parent training in children with pervasive developmental disorders and serious behavior problems: results from a randomized clinical trial. Journal of the American Academy of Child and Adolescent Psychiatry. 48: 1143-54. PMID 19858761 DOI: 10.1097/Chi.0B013E3181Bfd669  0.651
2009 Aman MG, Hollway JA, Leone S, Masty J, Lindsay R, Nash P, Arnold LE. Effects of risperidone on cognitive-motor performance and motor movements in chronically medicated children. Research in Developmental Disabilities. 30: 386-96. PMID 18768293 DOI: 10.1016/J.Ridd.2008.07.004  0.53
2008 Aman MG, Farmer CA, Hollway J, Arnold LE. Treatment of inattention, overactivity, and impulsiveness in autism spectrum disorders. Child and Adolescent Psychiatric Clinics of North America. 17: 713-38, vii. PMID 18775366 DOI: 10.1016/J.Chc.2008.06.009  0.597
2008 Aman MG, Hollway JA, McDougle CJ, Scahill L, Tierney E, McCracken JT, Arnold LE, Vitiello B, Ritz L, Gavaletz A, Cronin P, Swiezy N, Wheeler C, Koenig K, Ghuman JK, et al. Cognitive effects of risperidone in children with autism and irritable behavior. Journal of Child and Adolescent Psychopharmacology. 18: 227-36. PMID 18582177 DOI: 10.1089/Cap.2007.0133  0.578
2008 Clark DL, Arnold LE, Crowl L, Bozzolo H, Peruggia M, Ramadan Y, Bornstein R, Hollway JA, Thompson S, Malone K, Hall KL, Shelton SB, Bozzolo DR, Cook A. Vestibular Stimulation for ADHD: randomized controlled trial of Comprehensive Motion Apparatus. Journal of Attention Disorders. 11: 599-611. PMID 18198165 DOI: 10.1177/1087054707311042  0.319
2007 Arnold LE, Amato A, Bozzolo H, Hollway J, Cook A, Ramadan Y, Crowl L, Zhang D, Thompson S, Testa G, Kliewer V, Wigal T, McBurnett K, Manos M. Acetyl-L-carnitine (ALC) in attention-deficit/hyperactivity disorder: a multi-site, placebo-controlled pilot trial. Journal of Child and Adolescent Psychopharmacology. 17: 791-802. PMID 18315451 DOI: 10.1089/Cap.2007.018  0.408
2006 Williams SK, Scahill L, Vitiello B, Aman MG, Arnold LE, McDougle CJ, McCracken JT, Tierney E, Ritz L, Posey DJ, Swiezy NB, Hollway J, Cronin P, Ghuman J, Wheeler C, et al. Risperidone and adaptive behavior in children with autism. Journal of the American Academy of Child and Adolescent Psychiatry. 45: 431-9. PMID 16601648 DOI: 10.1097/01.Chi.0000196423.80717.32  0.598
2006 Lecavalier L, Aman MG, Scahill L, McDougle CJ, McCracken JT, Vitiello B, Tierney E, Arnold LE, Ghuman JK, Loftin RL, Cronin P, Koenig K, Posey DJ, Martin A, Hollway J, et al. Validity of the autism diagnostic interview-revised. American Journal of Mental Retardation : Ajmr. 111: 199-215. PMID 16597187 DOI: 10.1352/0895-8017(2006)111[199:Votadi]2.0.Co;2  0.486
2005 Arnold LE, Bozzolo H, Hollway J, Cook A, DiSilvestro RA, Bozzolo DR, Crowl L, Ramadan Y, Williams C. Serum zinc correlates with parent- and teacher- rated inattention in children with attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology. 15: 628-36. PMID 16190794 DOI: 10.1089/Cap.2005.15.628  0.465
2005 McDougle CJ, Scahill L, Aman MG, McCracken JT, Tierney E, Davies M, Arnold LE, Posey DJ, Martin A, Ghuman JK, Shah B, Chuang SZ, Swiezy NB, Gonzalez NM, Hollway J, et al. Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology. The American Journal of Psychiatry. 162: 1142-8. PMID 15930063 DOI: 10.1176/Appi.Ajp.162.6.1142  0.62
2003 Arnold LE, Vitiello B, McDougle C, Scahill L, Shah B, Gonzalez NM, Chuang S, Davies M, Hollway J, Aman MG, Cronin P, Koenig K, Kohn AE, McMahon DJ, Tierney E. Parent-defined target symptoms respond to risperidone in RUPP autism study: customer approach to clinical trials. Journal of the American Academy of Child and Adolescent Psychiatry. 42: 1443-50. PMID 14627879 DOI: 10.1097/00004583-200312000-00011  0.536
2002 McCracken JT, McGough J, Shah B, Cronin P, Hong D, Aman MG, Arnold LE, Lindsay R, Nash P, Hollway J, McDougle CJ, Posey D, Swiezy N, Kohn A, Scahill L, et al. Risperidone in children with autism and serious behavioral problems. The New England Journal of Medicine. 347: 314-21. PMID 12151468 DOI: 10.1056/Nejmoa013171  0.609
Show low-probability matches.